Hide filtersShow filters × Close Bryan, Garnier & Co acts as Sole Financial Advisor to German medical device CRO/CDMO seleon GmbH Bryan, Garnier & Co acts as Financial Advisor to the Boiron Family in the €875m tender offer for the BOIRON Group, world leader in natural medicine, in partnership with EW Healthcare Partners Bryan, Garnier & Co acts as Sole Financial Advisor to PhysioAssist on its $45m Sale to Inogen Bryan, Garnier & Co acts as Sole Financial Advisor to Physidia and its shareholders, a leading European renal care medtech company providing home haemodialysis solutions, on the sale of a majority stake to Columna Capital Bryan, Garnier & Co acts as Sole Financial Advisor to XVIVO on the acquisition of the Machine & Perfusion division from Avionord S.r.l. Bryan, Garnier & Co acts as Sole Financial Advisor to Oncodesign on the sale of its CRO activities to Elyan Partners for €100m and the concomitant spin-off of its Biotech/AI activities Bryan, Garnier & Co acts as Sole Financial Advisor to the shareholders of Grundium Oy on the sale of a majority stake to EW Healthcare Partners Bryan, Garnier & Co acts as Sole Financial Advisor to clinical-stage biologics company BiosanaPharma on its global strategic partnership with Alvotech Bryan, Garnier & Co acted as Sole Financial Advisor to the shareholders of CMN on its partnership with MBO & Co Bryan, Garnier & Co acts as Sole Financial Advisor to XVIVO on its acquisition of STAR Teams, and as Joint Global Coordinator on subsequent SEK 250 million Follow-on Offering Bryan, Garnier & Co acts as Sole Financial Advisor to FCDE on its acquisition of a majority stake in Didactic alongside its management team Bryan, Garnier & Co acts as Sole Financial Advisor to French telemedicine leader Qare on its acquisition by European digital health provider HealthHero
